Bdbrut 140mg Capsules: Product Overview
Bdbrut 140mg capsules contain ibrutinib 140mg, a targeted anticancer medicine belonging to the Bruton’s tyrosine kinase (BTK) inhibitor class. It is prescribed for certain blood cancers, including chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma, depending on the patient's clinical circumstances and applicable treatment indications.
Ibrutinib works by blocking BTK, a protein involved in the growth and survival of certain abnormal B cells. Treatment must be prescribed and monitored by a qualified healthcare professional.
Bdbrut 140mg Product Specifications
Key product details for buyers and pharmaceutical procurement teams include:
Brand name: Bdbrut
Active ingredient: Ibrutinib
Strength: 140mg
Dosage form: Oral capsule
Therapeutic category: Oncology / targeted cancer therapy
Manufacturer/marketer: BDR Pharmaceuticals Internationals Pvt Ltd, as listed in Indian medicine references
Pack information: Commonly listed in a bottle of 30 capsules; confirm the actual pack configuration before ordering.
Product availability, packaging, labelling and export eligibility should be verified before placing a purchase enquiry.
Bdbrut Capsules Supplier and Exporter in India
Cordium Pharmaceuticals Pvt Ltd supports enquiries for oncology medicines from international buyers seeking pharmaceutical sourcing from India. South African pharmaceutical importers, licensed distributors, hospitals and authorised procurement organisations can contact the company to discuss their requirements for Bdbrut 140mg capsules.
When evaluating an oncology medicine supplier, buyers should confirm product authenticity, manufacturer details, batch traceability, remaining shelf life, storage requirements and the availability of relevant quality and regulatory documents.
Cordium Pharmaceuticals Pvt Ltd can be approached for a product-specific supply enquiry, subject to confirmation of availability, applicable export permissions and destination-country requirements. No supply, registration or delivery timeline should be assumed until these details are confirmed.
Importing Bdbrut 140mg into South Africa
South African buyers should verify the regulatory status of the medicine and the requirements applicable to its importation before arranging procurement. Prescription medicines and oncology products may be subject to specific authorisation, licensing, registration and import-control requirements.
Importers should confirm the relevant requirements with the South African Health Products Regulatory Authority (SAHPRA) and other applicable authorities. A supplier quotation alone does not establish that a product is authorised for sale or import into South Africa.
Frequently Asked Questions
1. What is the composition of Bdbrut capsules?
Bdbrut 140mg capsules contain 140mg of ibrutinib, a targeted therapy used for certain blood cancers.
2. Can South African pharmaceutical buyers enquire about Bdbrut from India?
Yes. Buyers can contact Cordium Pharmaceuticals Pvt Ltd to enquire about product availability, export documentation and potential supply arrangements, subject to applicable regulations.
3. What information should buyers provide when requesting a quotation?
Provide the required strength, quantity, destination, buyer or importer details and any applicable regulatory documentation requirements.
4. Is Bdbrut available for purchase without a prescription?
Ibrutinib is a prescription oncology medicine. It should only be supplied and used through legally authorised channels, with appropriate medical supervision.
5. How can buyers contact Cordium Pharmaceuticals Pvt Ltd?
Contact the company through its official website to request a product-specific quotation and confirm availability, export eligibility and shipping requirements.
Request a Bdbrut 140mg Supply Enquiry
For Bdbrut 140mg capsules from India, contact Cordium Pharmaceuticals Pvt Ltd to discuss your pharmaceutical sourcing requirements. Product availability, pricing, documentation and shipment arrangements are subject to confirmation and applicable South African regulations.
Bdbrut 140mg capsules contain ibrutinib 140mg, a targeted anticancer medicine belonging to the Bruton’s tyrosine kinase (BTK) inhibitor class. It is prescribed for certain blood cancers, including chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma, depending on the patient's clinical circumstances and applicable treatment indications.
Ibrutinib works by blocking BTK, a protein involved in the growth and survival of certain abnormal B cells. Treatment must be prescribed and monitored by a qualified healthcare professional.
Bdbrut 140mg Product Specifications
Key product details for buyers and pharmaceutical procurement teams include:
Brand name: Bdbrut
Active ingredient: Ibrutinib
Strength: 140mg
Dosage form: Oral capsule
Therapeutic category: Oncology / targeted cancer therapy
Manufacturer/marketer: BDR Pharmaceuticals Internationals Pvt Ltd, as listed in Indian medicine references
Pack information: Commonly listed in a bottle of 30 capsules; confirm the actual pack configuration before ordering.
Product availability, packaging, labelling and export eligibility should be verified before placing a purchase enquiry.
Bdbrut Capsules Supplier and Exporter in India
Cordium Pharmaceuticals Pvt Ltd supports enquiries for oncology medicines from international buyers seeking pharmaceutical sourcing from India. South African pharmaceutical importers, licensed distributors, hospitals and authorised procurement organisations can contact the company to discuss their requirements for Bdbrut 140mg capsules.
When evaluating an oncology medicine supplier, buyers should confirm product authenticity, manufacturer details, batch traceability, remaining shelf life, storage requirements and the availability of relevant quality and regulatory documents.
Cordium Pharmaceuticals Pvt Ltd can be approached for a product-specific supply enquiry, subject to confirmation of availability, applicable export permissions and destination-country requirements. No supply, registration or delivery timeline should be assumed until these details are confirmed.
Importing Bdbrut 140mg into South Africa
South African buyers should verify the regulatory status of the medicine and the requirements applicable to its importation before arranging procurement. Prescription medicines and oncology products may be subject to specific authorisation, licensing, registration and import-control requirements.
Importers should confirm the relevant requirements with the South African Health Products Regulatory Authority (SAHPRA) and other applicable authorities. A supplier quotation alone does not establish that a product is authorised for sale or import into South Africa.
Frequently Asked Questions
1. What is the composition of Bdbrut capsules?
Bdbrut 140mg capsules contain 140mg of ibrutinib, a targeted therapy used for certain blood cancers.
2. Can South African pharmaceutical buyers enquire about Bdbrut from India?
Yes. Buyers can contact Cordium Pharmaceuticals Pvt Ltd to enquire about product availability, export documentation and potential supply arrangements, subject to applicable regulations.
3. What information should buyers provide when requesting a quotation?
Provide the required strength, quantity, destination, buyer or importer details and any applicable regulatory documentation requirements.
4. Is Bdbrut available for purchase without a prescription?
Ibrutinib is a prescription oncology medicine. It should only be supplied and used through legally authorised channels, with appropriate medical supervision.
5. How can buyers contact Cordium Pharmaceuticals Pvt Ltd?
Contact the company through its official website to request a product-specific quotation and confirm availability, export eligibility and shipping requirements.
Request a Bdbrut 140mg Supply Enquiry
For Bdbrut 140mg capsules from India, contact Cordium Pharmaceuticals Pvt Ltd to discuss your pharmaceutical sourcing requirements. Product availability, pricing, documentation and shipment arrangements are subject to confirmation and applicable South African regulations.
Keywords
